ONCT News and Press, Oncternal Therapeutics Inc. From 11/09/20

Gainers: Aptevo Therapeutics APVO +93%, Sundial Growers (SNDL) +93%, Oncternal Therapeutics (ONCT) +44%, Calliditas Therapeutics CALT +34%, Cogent Biosciences COGT +26%.Losers: Arcturus Therapeutics ARCT -39%, Quidel QDEL -32%, ...

Are These Biotech Penny Stocks On Your Watch List Right Now? Whether you’re trading penny stocks or blue chips , the goal is the same: make money and repeat. However, with a potentially new President coming into office, there could be a few things to monitor right now. Fi...

Listen on the go! A daily podcast of Wall Street Breakfast's Alpha Talks will be available this morning on Seeking Alpha, iTunes, Stitcher and Spotify. Stocks faded late to finish mostly flat on Friday, as investors awaited final election vote tallies in four key states, and stimulus negotiat...

Are These On Your List Of Penny Stocks To Watch Right Now? If you’re looking for penny stocks to buy right now , you’re likely going to begin with a list. I don’t need to tell you how important a list of penny stocks is during volatile times like these. But ...

Assembly Biosciences (ASMB) -55% on Q3 earnings release.Global Blood Therapeutics (GBT) -32% on Q3 earnings release.Epizyme (EPZM) -23% on Q3 earnings release.Marin Software (MRIN) -14% on Q3 earnings release.Hall of Fame Resort & Entertainment (HOF...

Are These Penny Stocks A BUY Right Now? Penny stocks have been seeing renewed attention in the past few weeks. With the election currently in flux and COVID on the rise, investors are always looking for the next opportunity. With penny stocks, volatility can be usually quite hig...

Gainers: Oncternal Therapeutics (ONCT) +131%, Aptevo Therapeutics (APVO) +42%, Aurora Cannabis (ACB) +36%, Tilray (TLRY) +29%, Akerna (KERN) +26%.Losers: Clovis Oncology (CLVS) -21%, bluebird bio (BLUE) -17%, Lannett Compan...

Thinly traded nano cap Oncternal Therapeutics ([[ONCT]] +78.1%) rockets on a whopping 543x surge in volume in apparent response to the release of an ASH abstract detailed updated results from an ongoing Phase 1/2 clinical trial evaluating lead candidate cirmtuzumab, combined with AbbVie ...

Gainers: Altus Midstream (ALTM) +150%.Hall of Fame Resort & Entertainment (HOFV) +118%.Oncternal Therapeutics (ONCT) +82%.Upwork (UPWK) +41%.Aptevo Therapeutics (APVO) +40%.Resideo Technologies (REZI) +35%.Aurora Cannabis (ACB) +34%.Kaixin Auto (KXIN) +33%.Falcon Minerals (...

Rare Pediatric Disease Designation received from FDA for TK216 for treatment of Ewing s arcoma Interim Phase 1 data for TK216 in 15 evaluable patients with relapsed/refractory Ewing s arcoma demonstrated two complete respon...